Trames Bio Overview
- Year Founded
-
2024
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Trames Bio General Information
Description
Developer of gene therapy technologies designed for the treatment of neurological disorders and chronic pain conditions. The company includes engineered viral vectors, gene delivery technologies, and therapeutic constructs focused on regulating neuronal activity and targeted gene expression, enabling biotechnology and healthcare markets to develop precision therapies for neurological diseases.
Contact Information
Website
www.tramesbio.comCorporate Office
- 1111 Broadway
- Suite 1300
- Oakland, CA 94607
- United States
Corporate Office
- 1111 Broadway
- Suite 1300
- Oakland, CA 94607
- United States
Trames Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Jun-2026 | Completed | Pre-Clinical Trials |
Trames Bio Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aditum Bio | Venture Capital | Minority |
Trames Bio FAQs
-
When was Trames Bio founded?
Trames Bio was founded in 2024.
-
Where is Trames Bio headquartered?
Trames Bio is headquartered in Oakland, CA.
-
What industry is Trames Bio in?
Trames Bio’s primary industry is Drug Discovery.
-
Is Trames Bio a private or public company?
Trames Bio is a Private company.
-
What is Trames Bio’s current revenue?
The current revenue for Trames Bio is .
-
Who are Trames Bio’s investors?
Aditum Bio has invested in Trames Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process